California State Teachers Retirement System (CalSTRS)’s Repare Therapeutics RPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-16,739
Closed -$202K 3080
2023
Q3
$202K Buy
16,739
+83
+0.5% +$857 ﹤0.01% 2503
2023
Q2
$176K Buy
16,656
+107
+0.6% +$1.1K ﹤0.01% 2563
2023
Q1
$163K Buy
16,549
+163
+1% +$1.87K ﹤0.01% 2605
2022
Q4
$241K Buy
16,386
+164
+1% +$2.45K ﹤0.01% 2583
2022
Q3
$197K Buy
16,222
+414
+3% +$5.33K ﹤0.01% 2639
2022
Q2
$221K Buy
15,808
+1,608
+11% +$18.9K ﹤0.01% 2651
2022
Q1
$202K Buy
14,200
+310
+2% +$4.6K ﹤0.01% 2647
2021
Q4
$293K Buy
13,890
+6,339
+84% +$149K ﹤0.01% 2672
2021
Q3
$198K Buy
+7,551
New +$244K ﹤0.01% 2746

Other funds holding RPTX

California State Teachers Retirement System (CalSTRS)'s RPTX Position: Q4 2023 in Review

California State Teachers Retirement System (CalSTRS) sold out of Repare Therapeutics (RPTX) in Q4 2023, closing a stake of 16,739 shares — an estimated $202K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in RPTX in Q3 2021 and held it in 9 quarters. The position peaked at $293K in Q4 2021. 69 funds tracked by Wall St. Rank hold RPTX as of Q4 2023.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Repare Therapeutics position as of Q4 2023 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 16,739 Repare Therapeutics shares in Q4 2023, an estimated $202K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Repare Therapeutics in Q3 2021 and held it in 9 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Repare Therapeutics position peaked at $293K in Q4 2021.
  • 69 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2023.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q4 2023, filed 13 Feb 2024.